Bone marrow transplantation improves the outcome of Atm-deficient mice through the migration of Atm-competent cells

Human Molecular Genetics

Volumn 22, Issue 3, 2013, Pages 493-507

  Pietzner, J ^a   Baer, P C ^b   Duecker, R P ^a   Merscher, M B ^a   Satzger prodinger, C ^c   Bechmann, I ^c   Wietelmann, A ^f   Del Turco, D ^c   Doering, C ^d   Kuci, S ^e   Bader, P ^e   Schirmer, S ^g   Zielen, S ^a   Schubert, R ^a  

^a Children's Hospital   (Germany)

^b Division of Nephrology   (Germany)

^c Institute for Clinical Neuroanatomy   (Germany)

^d SENCKENBERG RESEARCH INSTITUTE   (Germany)

^e GOETHE UNIVERSITY   (Germany)

^f MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^g UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA TELANGIECTASIA; BLOOD; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; BRAIN SIZE; CELL MIGRATION; CELL SURVIVAL; CEREBELLUM; LUNG; MOUSE; NONHUMAN; NONMYELOABLATIVE CONDITIONING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE SUBPOPULATION; THYMUS; THYMUS LYMPHOMA; WEIGHT GAIN; WILD TYPE;

ANIMALS; ATAXIA TELANGIECTASIA; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL CYCLE PROTEINS; CELL MOVEMENT; CHIMERISM; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; GENOTYPE; GREEN FLUORESCENT PROTEINS; LUNG; MAGNETIC RESONANCE IMAGING; MICE; MICE, TRANSGENIC; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHENOTYPE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SPLEEN; THYMUS GLAND; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; ATAXIA TELANGIECTASIA; MUS;

EID: 84872377291     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds448     Document Type: Article

References (56)

1. Gatti, R.A., Berkel, I., Boder, E., Braedt, G., Charmley, P., Concannon, P., Ersoy, F., Foroud, T., Jaspers, N.G. and Lange, K. (1988) Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature, 336, 577-580.
2. Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D.A., Smith, S., Uziel, T., Sfez, S. et al. (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science, 268, 1749-1753.
3. Savitsky, K., Sfez, S., Tagle, D.A., Ziv, Y., Sartiel, A., Collins, F.S., Shiloh, Y. and Rotman, G. (1995) The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet., 4, 2025-2032.
4. Uziel, T., Savitsky, K., Platzer, M., Ziv, Y., Helbitz, T., Nehls, M., Boehm, T., Rosenthal, A., Shiloh, Y. and Rotman, G. (1996) Genomic organization of the ATM gene. Genomics, 33, 317-320.
5. Ditch, S. and Paull, T.T. (2012) The ATM protein kinase and cellular redox signaling: beyond the DNA damage response. Trends Biochem. Sci., 37, 15-22.
6. Matsuoka, S., Ballif, B.A., Smogorzewska, A., McDonald, E.R., Hurov, K.E., Luo, J., Bakalarski, C.E., Zhao, Z., Solimini, N., Lerenthal, Y. et al. (2007) ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science, 316, 1160-1166.
7. Chun, H. and Gatti, R. (2004) Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst.), 3, 1187-1196.
8. Gatti, R.A., Becker-Catania, S., Chun, H.H., Sun, X., Mitui, M., Lai, C.H., Khanlou, N., Babaei, M., Cheng, R., Clark, C. et al. (2001) The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta Stone. Clin. Rev. Allergy Immunol., 20, 87-108.
9. Lavin, M.F. (2008) Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol., 9, 759-769.
10. Reichenbach, J., Schubert, R., Schwan, C., Muller, K., Bohles, H.J. and Zielen, S. (1999) Anti-oxidative capacity in patients with ataxia telangiectasia. Clin. Exp. Immunol., 117, 535-539.
11. Reichenbach, J., Schubert, R., Schindler, D., Müller, K., Böhles, H. and Zielen, S. (2002) Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid. Redox Signal, 4, 465-469.
12. Kieslich, M., Hoche, F., Reichenbach, J., Weidauer, S., Porto, L., Vlaho, S., Schubert, R. and Zielen, S. (2010) Extracerebellar MRI-lesions in ataxia telangiectasia go along with deficiency of the GH/IGF-1 axis, markedly reduced body weight, high ataxia scores and advanced age. Cerebellum, 9, 190-197.
13. Schubert, R., Reichenbach, J. and Zielen, S. (2005) Growth factor deficiency in patients with ataxia telangiectasia. Clin. Exp. Immunol., 140, 517-519.
14. Micol, R., Ben Slama, L., Suarez, F., Le Mignot, L., Beauté, J., Mahlaoui, N., Dubois d'Enghien, C., Laugé, A., Hall, J., Couturier, J. et al. (2011) Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype. J. Allergy Clin. Immunol., 128, 382-389.
15. Gueven, N., Luff, J., Peng, C., Hosokawa, K., Bottle, S.E. and Lavin, M.F. (2006) Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant. Free Radic. Biol. Med., 41, 992-1000.
16. Lavin, M.F., Gueven, N., Bottle, S. and Gatti, R.A. (2007) Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia. Br. Med. Bull, 81-82, 129-147.
17. Schubert, R., Erker, L., Barlow, C., Yakushiji, H., Larson, D., Russo, A., Mitchell, J.B. and Wynshaw-Boris, A. (2004) Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice. Hum. Mol. Genet., 13, 1793-1802.
18. Schubert, R., Schmitz, N., Pietzner, J., Tandi, C., Theisen, A., Dresel, R., Christmann, M. and Zielen, S. (2009) Growth hormone supplementation increased latency to tumourigenesis in Atm-deficient mice. Growth Factors, 27, 265-273.
19. Yorek, M.A., Dunlap, J.A., Manzo-Fontes, A., Bianchi, R., Berry, G.T. and Eichberg, J. (1999) Abnormal myo-inositol and phospholipid metabolism in cultured fibroblasts from patients with ataxia telangiectasia. Biochim. Biophys. Acta, 1437, 287-300.
20. Du, L., Damoiseaux, R., Nahas, S., Gao, K., Hu, H., Pollard, J.M., Goldstine, J., Jung, M.E., Henning, S.M., Bertoni, C. and Gatti, R.A. (2009) Nonaminoglycoside compounds induce readthrough of nonsense mutations. J. Exp. Med., 206, 2285-2297.
21. Jung, M.E., Ku, J.M., Du, L., Hu, H. and Gatti, R.A. (2011) Synthesis and evaluation of compounds that induce readthrough of premature termination codons. Bioorg. Med. Chem. Lett., 21, 5842-5848.
22. Lai, C.-H., Chun, H.H., Nahas, S.A., Mitui, M., Gamo, K.M., Du, L. and Gatti, R.A. (2004) Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons. Proc. Natl. Acad. Sci. USA, 101, 15676-15681.
23. Ayas, M., Al-Seraihi, A., El-Solh, H., Al-Ahmari, A., Khairy, A., Aldali, A., Markiz, S., Siddiqui, K. and Al-Jefri, A. (2011) The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells. Biol. Blood Marrow Transplant, 18, 627-632
24. de la Morena, M.T. and Gatti, R.A. (2011) A history of bone marrow transplantation. Hematol. Oncol. Clin. North Am., 25, 1-15.
25. Socié, G., Gluckman, E., Raynal, B., Petit, T., Landman, J., Devergie, A. and Brison, O. (1993) Bone marrow transplantation for Fanconi anemia using low-dose cyclophosphamide/thoracoabdominal irradiation as conditioning regimen: chimerism study by the polymerase chain reaction. Blood, 82, 2249-2256.
26. Brazelton, T.R., Rossi, F.M., Keshet, G.I. and Blau, H.M. (2000) From marrow to brain: expression of neuronal phenotypes in adult mice. Science, 290, 1775-1779.
27. Du, L., Pollard, J.M. and Gatti, R.A. (2007) Correction of prototypic ATM splicing mutations and aberrant ATM function with antisense morpholino oligonucleotides. Proc. Natl. Acad. Sci. USA, 104, 6007-6012.
28. Bagley, J., Cortes, M.L., Breakefield, X.O. and Iacomini, J. (2004) Bone marrow transplantation restores immune system function and prevents lymphoma in Atm-deficient mice. Blood, 104, 572-578.
29. Albert, M.H., Gennery, A.R., Greil, J., Cale, C.M., Kalwak, K., Kondratenko, I., Mlynarski, W., Notheis, G., Führer, M., Schmid, I. et al. (2010) Successful SCT for Nijmegen breakage syndrome. Bone Marrow Transplant, 45, 622-626.
30. Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, J.N., Ried, T., Tagle, D. et al. (1996) Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell, 86, 159-171.
31. McGrath-Morrow, S.A., Gower, W.A., Rothblum-Oviatt, C., Brody, A.S., Langston, C., Fan, L.L., Lefton-Greif, M.A., Crawford, T.O., Troche, M., Sandlund, J.T. et al. (2010) Evaluation and management of pulmonary disease in ataxia-telangiectasia. Pediatr. Pulmonol., 45, 847-859.
32. Cleaver, J.E. and Revet, I. (2008) Clinical implications of the basic defects in Cockayne syndrome and xeroderma pigmentosum and the DNA lesions responsible for cancer, neurodegeneration and aging. Mech. Ageing Dev., 129, 492-497.
33. Reiman, A., Srinivasan, V., Barone, G., Last, J.I., Wootton, L.L., Davies, E.G., Verhagen, M.M., Willemsen, M.A., Weemaes, C.M., Byrd, P.J. et al. (2011) Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours. Br. J. Cancer, 105, 586-591.
34. Przedborski, S., Levivier, M., Kostic, V., Jackson-Lewis, V., Dollison, A., Gash, D.M., Fahn, S. and Cadet, J.L. (1991) Sham transplantation protects against 6-hydroxydopamine-induced dopaminergic toxicity in rats: behavioral and morphological evidence. Brain Res., 550, 231-238.
35. Browne, S.E., Roberts, L.J., Dennery, P.A., Doctrow, S.R., Beal, M.F., Barlow, C. and Levine, R.L. (2004) Treatment with a catalytic antioxidant corrects the neurobehavioral defect in ataxia-telangiectasia mice. Free Radic. Biol. Med., 36, 938-942.
36. Reliene, R. and Schiestl, R.H. (2006) Antioxidant N-acetyl cysteine reduces incidence and multiplicity of lymphoma in Atm deficient mice. DNA Repair (Amst.), 5, 852-859.
37. Erker, L., Schubert, R., Elchuri, S., Huang, T.-T., Tarin, D., Mueller, K., Zielen, S., Epstein, C.J. and Wynshaw-Boris, A. (2006) Effect of the reduction of superoxide dismutase 1 and 2 or treatment with alpha-tocopherol on tumorigenesis in Atm-deficient mice. Free Radic. Biol. Med., 41, 590-600.
38. D'Agostino, B., Sullo, N., Siniscalco, D., de Angelis, A. and Rossi, F. (2010) Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease. Expert Opin. Biol. Ther, 10, 681-687.
39. Kähler, C.M., Wechselberger, J., Hilbe, W., Gschwendtner, A., Colleselli, D., Niederegger, H., Boneberg, E.M., Spizzo, G., Wendel, A., Gunsilius, E., Patsch, J.R. and Hamacher, J. (2007) Peripheral infusion of rat bone marrow derived endothelial progenitor cells leads to homing in acute lung injury. Respir. Res., 8, 50.
40. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G. and Isner, J.M. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275, 964-967.
41. Bernardo, M.E., Locatelli, F. and Fibbe, W.E. (2009) Mesenchymal stromal cells. Ann. N. Y. Acad. Sci, 1176, 101-117.
42. Beckett, T., Loi, R., Prenovitz, R., Poynter, M., Goncz, K.K., Suratt, B.T. and Weiss, D.J. (2005) Acute lung injury with endotoxin or NO2 does not enhance development of airway epithelium from bone marrow. Mol. Ther., 12, 680-686.
43. Herzog, E.L., van Arnam, J., Hu, B. and Krause, D.S. (2006) Threshold of lung injury required for the appearance of marrow-derived lung epithelia. Stem. Cells, 24, 1986-1992.
44. Boder, E. (1975) Ataxia-telangiectasia: some historic, clinical and pathologic observations. Birth Defects Orig. Artic. Ser., 11, 255-270.
45. Kamiya, M., Yamanouchi, H., Yoshida, T., Arai, H., Yokoo, H., Sasaki, A., Hirato, J., Nakazato, Y., Sakazume, Y. and Okamoto, K. (2001) Ataxia telangiectasia with vascular abnormalities in the brain parenchyma: report of an autopsy case and literature review. Pathol. Int., 51, 271-276.
46. Paula-Barbosa, M.M., Ruela, C., Tavares, M.A., Pontes, C., Saraiva, A. and Cruz, C. (1983) Cerebellar cortex ultrastructure in ataxia-telangiectasia. Ann. Neurol., 13, 297-302.
47. Herzog, E.L., Chai, L. and Krause, D.S. (2003) Plasticity of marrow-derived stem cells. Blood, 102, 3483-3493.
48. Hess, D.C., Hill, W.D., Carroll, J.E. and Borlongan, C.V. (2004) Do bone marrow cells generate neurons? Arch. Neurol., 61, 483-485.
49. Priller, J., Persons, D.A., Klett, F.F., Kempermann, G., Kreutzberg, G.W. and Dirnagl, U. (2001) Neogenesis of cerebellar Purkinje neurons from gene-marked bone marrow cells in vivo. J. Cell Biol., 155, 733-738.
50. Alvarez-Dolado, M., Pardal, R., Garcia-Verdugo, J.M., Fike, J.R., Lee, H.O., Pfeffer, K., Lois, C., Morrison, S.J. and Alvarez-Buylla, A. (2003) Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature, 425, 968-973.
51. Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.-K., Mack, M., Heikenwalder, M., Brück, W., Priller, J. and Prinz, M. (2007) Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat. Neurosci., 10, 1544-1553.
52. Jones, J., Jaramillo-Merchán, J., Bueno, C., Pastor, D., Viso-León, M. and Marti{dotless}́nez, S. (2010) Mesenchymal stem cells rescue Purkinje cells and improve motor functions in a mouse model of cerebellar ataxia. Neurobiol. Dis., 40, 415-423.
53. Borghesani, P.R., Alt, F.W., Bottaro, A., Davidson, L., Aksoy, S., Rathbun, G.A., Roberts, T.M., Swat, W., Segal, R.A. and Gu, Y. (2000) Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice. Proc. Natl. Acad. Sci. USA, 97, 3336-3341.
54. Kuljis, R.O., Xu, Y., Aguila, M.C. and Baltimore, D. (1997) Degeneration of neurons, synapses, and neuropil and glial activation in a murine Atm knockout model of ataxia-telangiectasia. Proc. Natl. Acad. Sci. USA, 94, 12688-12693.
55. Li, J., Chen, J., Vinters, H.V., Gatti, R.A. and Herrup, K. (2011) Stable brain ATM message and residual kinase-active ATM protein in ataxia-telangiectasia. J. Neurosci., 31, 7568-7577.
56. Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T. and Nishimune, Y. (1997) 'Green mice' as a source of ubiquitous green cells. FEBS Lett., 407, 313-319